Betaleukin in therapy of chronic hepatitis C
The article presents the problems of modern antiviral therapy of chronic hepatitis C. The effectiveness of combined therapy with pegylated interferon and ribavirin in patients infected with 1st genotype is not more than 50%. Inclusion in the therapy HCV’s protease inhibitors (telaprevir and boceprev...
Shranjeno v:
| Principais autores: | , , |
|---|---|
| Format: | Artigo |
| Jezik: | Russo |
| Izdano: |
Journal Infectology
2014-10-01
|
| Serija: | Журнал инфектологии |
| Teme: | |
| Online dostop: | https://journal.niidi.ru/jofin/article/view/336 |
| Oznake: |
Brez oznak, prvi označite!
|